市場調查報告書

乳房攝影篩檢的全球市場:成長率,趨勢及預測分析(2019年∼2024年)

Breast Imaging Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 661006
出版日期 內容資訊 英文 115 Pages
商品交期: 2-3個工作天內
價格
乳房攝影篩檢的全球市場:成長率,趨勢及預測分析(2019年∼2024年) Breast Imaging Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 115 Pages
簡介

全球乳房攝影篩檢市場上,乳癌的盛行率增加,乳癌成像領域的技術進步,各種組織對乳癌篩檢宣傳活動的投資等成為主要的促進成長因素。根據Breast Cancer Now 2018報告,在英國每年有50,000名以上的女性和約350名男性診斷出乳癌。每月約1,000名女性死於乳癌。另一方面,乳房攝影篩檢診斷上,實驗對象或患者因治療目暴露於放射線數次。可是,放射線治療對患者的健康並非完全有益。因此,胸部檢驗相關的錯誤和副作用,成為妨礙市場成長的主要原因。

本報告提供全球乳房攝影篩檢市場相關調查分析,市場概要,市場動態,市場區隔,各地區的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 簡介

  • 調查的成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 乳癌的盛行率增加
    • 乳房攝影篩檢領域的技術進步
    • 各種組織對乳癌診察宣傳活動的投資
  • 市場阻礙因素
    • 暴露於放射線造成弊病的風險
    • 開發中國家的篩檢檢驗的高成本
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 競爭的強度

第5章 市場區隔

  • 成像各技術種類
    • 乳房X光攝影
    • 乳房用超音波
    • 乳房用MRI
    • 生物標記
    • 正子放出乳房X光攝影
    • 影像誘導乳房切片
    • 其他
  • 各終端用戶
    • 醫院
    • 診斷中心
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲地區
    • 南美

第6章 競爭情形

  • 企業概要
    • FUJIFILM Holdings
    • GE Healthcare
    • Hologic Inc.
    • General Medical Merate SpA
    • Koninklijke Philips NV
    • Aurora Health Care
    • Canon
    • CMR Naviscan Corporation
    • SonoCine,Inc.
    • 東芝
    • Dilon Technologies,Inc.

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 48382

Breast Imaging market is primarily driven by the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns. According to Breast Cancer Care WA, it is estimated that in 2019, 19,371 Australian women were diagnosed with breast cancer or approximately 53 each day, which accounts for approximately 14% of all new cancer cases diagnosed in 2019. On the other hand, in breast imaging procedures the subject or patient is exposed to multiple sets of radiations for therapeutic purposes. However, radiation therapy is not always good for the patient's health. Hence, the errors and side effects associated with breast screening is a major restraining factor for the growth of the market studied.

Key Market Trends

Mammography holds the major share in Global Breast Imaging Market

  • The mammography segment of the global breast imaging market is growing due to the many initiatives taken for the early detection of breast cancer. For instance, the United States Preventive Services Task Force has developed guidelines for mammography screening.
  • Additionally, the National Cancer Institute conducts and facilitates many organizations to develop their guidelines. Breast cancer is one of the leading causes of death among women. Since mammography is the standard technique used to screen breast cancer, governments and other healthcare organizations around the world are taking initiatives to provide women, between the ages of 50 and 75, access to mammography screening. This is increasing the global demand for mammography.
  • In addition, there have been a number of advancements in the field that prevent over-diagnosis and provide better sensitivity to detect smaller carcinomas. These continuous advancements in this field are expected to augment the mammography segment of global breast cancer screening tests market.

North America Accounts for the Largest Share in Global Breast Imaging Market

The number of cancer patients in North America has witnessed a considerable rise. Prostate and breast cancer are the most prevalent forms of cancer in the region. According to BreastCancer.org, as of January 2019, there were more than 3.1 million women with a history of breast cancer in the United States and the death rates were higher for breast cancer than any other cancer.

The American Cancer Society is playing a vital role in early research to demonstrate the feasibility of mass screening for breast cancer, joining hands with the National Cancer Institute on the nationwide Breast Cancer Detection Demonstration Project. There are initiatives, such as the United States Preventive Services Task Force (USPSTF), made up of doctors and specialists who are researching ways to prevent diseases or detect them early. These societies are spreading awareness among people regarding the benefits of early breast cancer diagnosis and treatment. These factors, as well as the growing innovations in breast cancer imaging techniques, are expected to drive the global breast imaging market.

Competitive Landscape

Breast Imaging Market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence, by introducing new products and reducing the side effects of the procedures. Key players present in the market include Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., General Medical Merate SpA, Koninklijke Philips NV among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Prevalence of Breast Cancer
    • 4.2.2 Technological Advancements in the Field of Breast Imaging
    • 4.2.3 Investments and Initiatives from Various Organizations in Breast Cancer Screening Campaigns
  • 4.3 Market Restraints
    • 4.3.1 Risk of Adverse Effects from Radiation Exposure
    • 4.3.2 High Cost of Imaging Systems
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type of Imaging Technique
    • 5.1.1 Mammography
    • 5.1.2 Breast Ultrasound
    • 5.1.3 Breast MRI
    • 5.1.4 Positron Emission Mammography
    • 5.1.5 Image-guided breast biopsy
    • 5.1.6 Other Imaging Techniques
  • 5.2 By End Users
    • 5.2.1 Hospitals
    • 5.2.2 Diagnostic Centers
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Fujifilm Holdings Corporation
    • 6.1.2 GE Healthcare
    • 6.1.3 Hologic Inc.
    • 6.1.4 General Medical Merate S.p.A.
    • 6.1.5 Koninklijke Philips NV
    • 6.1.6 Aurora Health Care
    • 6.1.7 Canon Inc.
    • 6.1.8 CMR Naviscan Corporation
    • 6.1.9 SonoCine, Inc.
    • 6.1.10 Siemens Healthineers
    • 6.1.11 Dilon Technologies, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS